Movicol Pediátrico Sabor Neutro

Polyethylene glycol 3350, electrolytes, the active ingredient in Movicol Pediátrico Sabor Neutro, is an osmotic laxative presented as an oral solution for oral use. It treats constipation in pediatric patients.

GNH USA supplies Movicol Pediátrico Sabor Neutro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Movicol Pediátrico, an osmotic laxative, is indicated for the management of constipation in children.

- Constipation: softens stool and promotes regular bowel movements in pediatric patients. - Fecal impaction: helps relieve hard stool accumulation in children. - Chronic functional constipation: supports long‑term bowel regulation for ongoing pediatric constipation.

Common Side Effects: - Abdominal bloating: feeling of fullness or swelling in the abdomen. - Nausea: mild to moderate sensation of wanting to vomit. - Flatulence: increased intestinal gas. - Diarrhea: loose, watery stools. - Abdominal pain: cramping or discomfort in the stomach area. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Severe electrolyte imbalance: abnormal levels of sodium, potassium, or chloride. - Dehydration: excessive loss of body fluids. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Severe abdominal cramps: intense, persistent stomach pain. - Rectal bleeding: presence of blood in stool. - Acute renal failure: sudden loss of kidney function (very rare).

Before initiating therapy, consider the following precautions: - Hydration status: assess and ensure adequate fluid intake. - Electrolyte monitoring: check serum electrolytes, especially in prolonged use. - Renal impairment: use with caution in patients with reduced kidney function. - Intestinal obstruction: avoid if there is known blockage of the bowel. - Pediatric dosing: adjust dose according to weight and age as prescribed. - Store at ambient temperature: keep in the original pack, protect from moisture.

When co‑administered with other medicines, be aware of potential interactions:

Major Interactions (Avoid): - Other osmotic laxatives: risk of severe electrolyte loss and dehydration. - Loop diuretics: may exacerbate potassium depletion. - Lithium: altered lithium serum concentrations. - Anticholinergic agents: may reduce laxative efficacy. - High‑dose magnesium‑containing antacids: increased risk of electrolyte imbalance.

Moderate Interactions (Monitor Closely): - Oral rehydration solutions: monitor for shifts in electrolyte balance. - ACE inhibitors: watch for changes in potassium levels. - NSAIDs: may increase risk of renal impairment when combined with laxatives. - Oral antibiotics: possible alteration of gut flora affecting stool consistency. - Vitamin C supplements (high dose): may enhance osmotic effect.